Inventor · disambiguated record
Walter P. Carney
Also filed as: CARNEY WALTER · CARNEY WALTER P · CARNEY WALTER PATRICK
13 granted patents·12 pending applications·541 citations·filing 1987–2013
93Inventor score
Files withCARNEY WALTER P4ONCOGENE SCIENCE INC4ELTING JAMES J3SIEMENS HEALTHCARE DIAGNOSTICS3BAYER AG2
Top patents by PatentIndex Score
25 records- 0195US5401638ADetection and quantification of neu related proteins in the biological fluids of humansONCOGENE SCIENCE INC·Filed 1991·Granted Mar 28, 1995·276 cites·11 claims
- 0292US5604107ADetection of neu p185 in cell lysatesONCOGENE SCIENCE INC·Filed 1994·Granted Feb 18, 1997·118 cites·38 claims
- 0371US5084380AMonoclonal antibodies reactive with activated and oncogenic ras p21 proteinsAPPLIED BIOTECHNOLOGY·Filed 1989·Granted Jan 28, 1992·28 cites·3 claims
- 0465US5028527AMonoclonal antibodies against activated ras proteins with amino acid mutations at position 13 of the proteinAPPLIED BIO TECHNOLOGY·Filed 1988·Granted Jul 2, 1991·20 cites·8 claims
- 0562US5443956ADetection, quantitation and classification of RAS proteins in body fluids and tissuesONCOGENE SCIENCE INC·Filed 1993·Granted Aug 22, 1995·26 cites·6 claims
- 0662US5081230AMonoclonal antibodies reactive with normal and oncogenic forms of the ras p21 proteinDU PONT·Filed 1987·Granted Jan 14, 1992·15 cites·5 claims
- 0758US6861511B1Detection and quantification of neu related proteins in the biological fluids of humansBAYER AG·Filed 1995·Granted Mar 1, 2005·22 cites·9 claims
- 0856US7732159B2Assays for cancer patient monitoring based on levels of analyte components of the plasminogen activator system in body fluid samplesSIEMENS HEALTHCARE DIAGNOSTICS·Filed 2007·Granted Jun 8, 2010·0 cites·34 claims
- 0954US2012220524A1Assays for cancer patient monitoring based on levels of analyte components of the plasminogen activator system in body fluid samplesCARNEY WALTER P·Filed 2012·Application pending·0 cites
- 1052US7473534B2Assays for cancer patient monitoring based on levels of epidermal growth factor receptor (EGFR) extracellular domain (ECD) analyte, alone or in combination with other analytes, in body fluid samplesSIEMENS HEALTHCARE DIAGNOSTICS·Filed 2003·Granted Jan 6, 2009·3 cites·9 claims
- 1151US6200764B1Detection, quantitation and classification of ras proteins in body fluids and tissuesBAYER AG·Filed 1995·Granted Mar 13, 2001·15 cites·15 claims
- 1250US2014093890A1Quantitative assays for ras p21 in body fluidsCARNEY WALTER P·Filed 2013·Application pending·0 cites
- 1349US4898932AMonoclonal antibodies reactive with activated and oncogenic ras p21 proteinsDU PONT·Filed 1987·Granted Feb 6, 1990·12 cites·13 claims
- 1449US2009286268A1Assays for Cancer Patient Monitoring Based on Levels of Analyte Components of the Plasminogen Activator System in Body Fluid SamplesCARNEY WALTER P·Filed 2009·Application pending·0 cites
- 1549US2010267058A1Circulating ret receptorSIEMENS HEALTHCARE DIAGNOSTICS·Filed 2008·Application pending·0 cites
- 1648US2011281279A1CIRCULATING Epha2 RECEPTORHAMER PETER·Filed 2008·Application pending·0 cites
- 1747US2003180819A1Assays for cancer patient monitoring based on levels of analyte components of the plasminogen activator system in body fluid samplesFiled 2003·Application pending·0 cites
- 1845US2010167324A1Quantitative Assays for Ras p21 in Body FluidsCARNEY WALTER P·Filed 2006·Application pending·0 cites
- 1944US2008311604A1Methods for Prediction and Prognosis of Cancer, and Monitoring Cancer TherapyELTING JAMES J·Filed 2006·Application pending·0 cites
- 2044US2008311601A1Methods for Prediction and Prognosis of Cancer, and Monitoring Cancer TherapyELTING JAMES J·Filed 2006·Application pending·0 cites
- 2143US2009221010A1Methods for Prediction and Prognosis of Cancer, and Monitoring Cancer TherapyELTING JAMES J·Filed 2006·Application pending·0 cites
- 2243US2007037224A1Quantitative assays for PDGFR-beta in body fluidsHAMER PETER J·Filed 2006·Application pending·0 cites
- 2340US2014154703A1Circulating tumor cell capture on a microfluidic chip incorporating both affinity and sizeSKELLEY ALISON·Filed 2012·Application pending·0 cites
- 2435US5262523AAntibodies reactive with normal and oncogenic forms of the ras p21 proteinONCOGENE SCIENCE INC·Filed 1991·Granted Nov 16, 1993·2 cites·6 claims
- 2532US5112737AMonoclonal antibodies against activated ras proteins with amino acid mutations at position 13 of the proteinAPPLIED BIOTECHNOLOGY INC·Filed 1991·Granted May 12, 1992·4 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Walter P. Carney files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →